Member Info for Globex

FT: Switzerland in fresh push to woo Donald Trump on tariffs

https://www.ft.com/content/a470c79c-9d38-453e-b3d1-3a743d7d3c9c

Rolex meeting gets a mention. No deal on tariffs yet but all not lost here.

I mean buying at today's price seems a decent bet to me with potential upside from this base, but 2p+, what were you thinking?

2p+ I should say lol

Buried_treasure

Afraid you lost all credibility when it was revealed you originally bought these at 2p and the loss you suffered is only reason you're so keen to give it large on this particular stock.

Saving grace here is that regulatory winds are blowing in right direction.

Latest sign is an Aquis listed stock (KR1) announcing their plans to move to main market and positively engaging with FCA to get approval. All KR1 do is hold altcoins, no trading business - so if FCA give even that company the go ahead, would represent a real green light for sector. FCA are definitely showing an increasing willingness to approve crypto products. This prospectus will get approved, only thing we don't know is timing, but once it's greenlit we're game on again.

This confirm Ixico's involvement with Uniqure's study. Massive news imo, when that made global news and sent Uniqure's stock up 250% (even though it already valued in the $billions).

I believe the market hasn't picked up on this yet because the company haven't issued an RNS - surely a no brainer for them to do so.

Https://www.linkedin.com/posts/ixico_a-landmark-moment-in-huntingtons-disease-activity-7376903070737248257-ZhP1

"IXICO are proud to be have been involved in the clinical trial providing imaging reads & analysis and are delighted for the incredible patients and researchers that contributed to this landmark moment in HD research. The results provide great example of innovative precision medicine in action."

Seems the buy high sell low crew are out now, and last bull has left the building. FWIW times like this often when a floor is hit on a momentum driven stock like we have here.

May or may not also be worth noting founder last bought shares around this price, he still has a say here and can't imagine he'll be keen to see it drop much more than this.

We even have another tentative bottom signal for the chartists, being very close to 50% fibonacci retracement from June peak.

All to play for but bigger picture this is a company with promising gold assets in safe jurisdictions when the price of gold has never been higher.

GL

This should merge with ABDX. Both in testing business with Boots as significant customer. Tons of synergies that could be unlocked. One board, one set of managers, cost savings go without saying. Both have seen revenue drop off a cliff in last few years, this way they'd get strength in numbers. Realistically neither company generating enough cash to justify the listing costs as independents.

One of those rare opportunities to be ahead of the crowd here, very pleased to have bought in today.

Good point. Uniqure stock did 250% yesterday. Market hasn't quite realised what we have here. Next biotech multi bagger?

As stated, they have already set out future dividend policy - it will depend on EPS.

Makes no sense for anyone to try and guess yield without looking at EPS.

Staff costs higher proportionately due to lack of scale vs peers, and they didn't start cutting monks soon enough, now playing catch up with revenue decline.

Forecasts wise everything you say is sensible, the wildcard is Sorrell's now legendary inability to ever produce accurate guidance.

You never know, maybe this time will be different and he'll be right, but caveat emptor. As the saying goes, fool me once that's on me, fool me with nearly all the trading updates since 2022 maybe we can't take this at face value like we can with any other normal company. Or something like that.

Annual report has details: "new dividend policy of paying out a minimum of 50% of Adjusted diluted EPS and returning excess capital to shareholders via share buybacks." So depends on EPS, until that known post year end no point guessing really. Company indicate they'll retain a bit more cash for M&A.

It's looked extremely cheap for a while but unfortunately there are good reasons for it. The business is facing challenges on multiple fronts.

The decline of print media meant everything hinged on digital but that too has had a couple of hammer blows.

First was social media algo changes, particularly Facebook that overnight stopped diverting meaningful traffic to news sites.

Second the rise of AI means any old idiot can set up endless websites or apps and churn out infinite articles about any subject, so it has become a race to the bottom competing for traffic. Reach being lowbrow means they don't have the same sort of inbuilt defence proper publications like FT or Guardian have.

Latest hammer blow for all publishers is google AI summaries now rapidly reducing need to click through to separate websites. The more sophisticated AI gets the more integrated with the apps it becomes, creating a bit of a doom loop as with less traffic they serve fewer advertisers generating less revenue.

You've contradicted yourself a bit here, you implied Argos came with £700m cash, but after my post you are now saying something different.

Media reports are correct. The company's accounts do give currently Argos a book value of £344m.

Market likes it, could be a decent turnaround play now from this low base. It is interesting to see the wording around Africa seems to be hardening. Indicates they are progressing with the long discussed exit and potentially beyond just abandoning Nigeria.

Still a lot to prove, but best case scenario would be if they managed to extricate themselves from the continent while realising a decent price from assets. Would then be a much stronger investment prospect without all the associated forex / political instability woes.

First word typo, lost a W on the way

Hat is odd is how we've ended up with a couple of resident jobsworth/traffic warden types trying to control discussion they don't approve of here, yet compared to most busy boards has been one of the far more reasonable ones. Or at least it was before these rocked up.

I mean just look at the leaderboard on any particular day, or X, you name it, you will all sorts of outlandish stuff being written. You'd think they'd have a field day policing that lot. Yet they've wound up here?

Absolutely bizarre we're in a situation where one of them is trying to have a go even about linking to an FT article around improvements towards regulatory environment towards crypto in UK - this being the board of a UK stock with exposure to both crypto and funnily enough the UK regulatory environment.

If you see these boards as so beneath you, why do you continue to interact with them?